- Beacon
Securities Limited argues that Sunniva’s Canadian greenhouse alone is
worth more than its entire market cap
- California
facility, Canadian cannabis clinics add to company’s value
- Sunniva
also bolstered by agreement with licensed producer Canopy Growth Corp.
amid heightened M&A activity in cannabis sector
Cannabis supplier Sunniva Inc.’s (CSE: SNN)
(OTCQX: SNNVF) strengthening foothold in California’s and Canada’s
consumer-populated markets has been failing to translate to its stock price and
market cap since it began trading on the Canadian Securities Exchange and the
U.S. OTCQX® Best Market in January, leading investment researchers at Beacon
Securities Limited (http://ibn.fm/K5a88)
to classify Sunniva’s public offering as a “badly mispriced” listing that could
reward investors who buy in at undervalued levels reported at the time of its
July 30 market update, titled ‘Sunniva Inc. (CSE: SNN) California Dreams Have
Never Been This Cheap’.
Beacon Securities argues that Sunniva’s assets in Canada are
worth more than the company’s entire current $180 million market cap and that
its near-commercialization property in California is effectively being given
zero value, “or, in fact, negative — a proposition that is ludicrous given the
imminent launch of its 489,000 SF greenhouse (with on-site dispensary and
distribution license) in the world’s largest cannabis market in California.”
The company’s Canadian assets include a 740,000-square-foot
greenhouse in British Columbia that has been permitted and has solidified a
take-or-pay agreement with licensed producer Canopy Growth Corp. (TSX: WEED)
(OTC: TWMJF) for 45 percent of its output. Beacon notes the heightened pace of
merger and acquisition transactions in the cannabis marketplace and opines that
it would not be surprising if Canopy buys Sunniva’s Canadian assets just to
secure a quality production pipeline.
Beacon anticipates a potential valuation of $250 million for
Sunniva’s facility in the community of Okanagan Falls, an unincorporated area
45 kilometers (28 miles) north of the U.S.-Canada border, and it adds the $10
million of yearly revenue generated by Sunniva’s seven medical clinics that
could be vertically integrated as a distributor of the facility’s production.
“In summary, we believe the current market cap of Sunniva
reflects neither the value of (its) Canadian or US assets. With M&A heating
up in both Canada and the US, we believe investors will be rewarded upon buying
shares at current levels, especially given the leadership team’s significant
experience in maximizing shareholder value,” Beacon’s report concludes.
CEO Anthony Holler told industry trade magazine Public
Entrepreneur that the Cathedral City, California, operation should
begin production in the third quarter of this year, with the possibility of
delivering its first crop before year-end, even before it achieves full-scale
operation (http://ibn.fm/edVkx).
Notably, the company is good manufacturing practices certified, which also
gives it gravitas with international markets.
For more information, visit the company’s website at www.sunniva.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
